Life Pain Specialists (LPS) With a Focus on Patient Pain Management and Prevention of Substance Misuse
|The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.|
|ClinicalTrials.gov Identifier: NCT04154384|
Recruitment Status : Enrolling by invitation
First Posted : November 6, 2019
Last Update Posted : November 14, 2019
|Condition or disease||Intervention/treatment||Phase|
|Opioid Use||Behavioral: Patient Pain Plan (PPP)||Not Applicable|
Opioids are psychoactive substances (narcotics) primarily used for pain relief by producing morphine-like effects. Although regularly prescribed by physicians, opioids (including morphine, codeine, and oxycodone) are highly addictive. Opioids block feelings of pain and trigger a release of dopamine. Dependence occurs with repeated use, as the parts of the brain naturally responsible for releasing dopamine rely on the drug for proper function. When avoided, patients quickly experience severe withdrawal symptoms similar to the flu.
In the United States, millions are prescribed opioids for pain relief. Every day, more than 115 people die from overdose. The highest among them are people aged 25 to 54 years. Addiction treatment costs near $78.5 billion and rising, less than 10% of people in need are receiving it.
Within the orthopaedic trauma population at Grady Healthcare in Atlanta, Georgia, 20% of patients report a history of substance abuse, 30% have previously used opioid medications for pain, and nearly 25% report taking opioid pain medications up to 1 year after their trauma. Trauma patients are particularly at high risk.
The Christopher Wolf Crusade (CWC) is a 501C3 non-profit providing preventative solutions, education, and advocacy for the American opioid epidemic. CWC's primary focus is to introduce a behavior-specific intervention at the time of inpatient hospitalization for trauma to decrease overall opioid utilization and improve pain control in the post-trauma time period. The goal of this study is to introduce Life Pain Specialists (LPS) to the healthcare field to focus on pain management and addiction prevention for patients. The LPS is a behavior-based pain "coach" who educates patients on risks of opioid dependence and offers non-traditional non-pharmacologic options for pain control. In addition, the LPS will act as a liaison between the patient and the physician to ensure that traditional pharmacologic-based pain control regimens are optimized.
Potential patients will be identified during their initial presentation to Grady Hospital during morning trauma board rounds within the first 24 hours of admission. Once the consent process is complete, the participants will be referred to the LPS team. Participants will be followed in the orthopaedic trauma clinic at routine post-operative intervals (2 weeks, 6 weeks, 3 months, 6 months, and 1 year post-operatively).
|Study Type :||Interventional (Clinical Trial)|
|Estimated Enrollment :||200 participants|
|Intervention Model:||Single Group Assignment|
|Masking:||None (Open Label)|
|Official Title:||Life Pain Specialists (LPS) With a Focus on Patient Pain Management and Prevention of Substance Misuse|
|Estimated Study Start Date :||November 2019|
|Estimated Primary Completion Date :||September 2022|
|Estimated Study Completion Date :||September 2022|
Experimental: Patient Pain Plan (PPP)
Orthopedic trauma patients will work with a Life Pain Specialist (LPS) and will receive a personalized Patient Pain Plan (PPP) to avoid potential opioid misuse.
Behavioral: Patient Pain Plan (PPP)
The Life Pain Specialist (LPS) will work with the patient to develop a Patient Pain Plan (PPP) focused on behavioral education, and will act as a liaison with physicians to optimize the pharmacologic component of pain management. The PPP includes education about substance misuse and provides non-pharmacological pain management options.
- Opioid Pain Medication Usage [ Time Frame: Month 12 ]The primary outcome of the study will be the utilization of opioid pain medication at 1 year after the operation. This value will be compared to the 23% of a historical control cohort reporting continuing to use opioids a year post operation.
- Change in Pain Score [ Time Frame: Week 2, Week 6, Month 3, Month 6, Month 12 ]Pain will be assessed using an 11-point Likert scale where 0 = no pain and 10 = severe pain.
- Change in Opioid Utilization [ Time Frame: Day 1 (at hospital discharge), Week 2, Week 6 ]Opioid utilization will be recorded in morphine equivalents.
To learn more about this study, you or your doctor may contact the study research staff using the contact information provided by the sponsor.
Please refer to this study by its ClinicalTrials.gov identifier (NCT number): NCT04154384
|United States, Georgia|
|Grady Health System|
|Atlanta, Georgia, United States, 30322|
|Principal Investigator:||Mara Schenker, MD||Emory University|